Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer

被引:17
|
作者
Nakamura, Ryota [2 ]
Kurishima, Koichi [3 ]
Kobayashi, Naohiro [2 ]
Ishikawa, Shigemi [2 ]
Goto, Yukinobu [2 ]
Sakai, Mitsuaki [2 ]
Onizuka, Masataka [2 ]
Ishikawa, Hiroichi [4 ]
Satoh, Hiroaki [1 ,3 ]
Hizawa, Nobuyuki [3 ]
Sato, Yukio [2 ]
机构
[1] Univ Tsukuba, Mito Med Ctr, Dept Internal Med, Mito, Ibaraki 3100015, Japan
[2] Univ Tsukuba, Div Cardiovasc Thorac Surg, Mito, Ibaraki 3100015, Japan
[3] Univ Tsukuba, Inst Clin Med, Mito, Ibaraki 3100015, Japan
[4] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan
来源
ONKOLOGIE | 2010年 / 33卷 / 1-2期
关键词
Non-small cell lung cancer; Surgery; Postoperative; Follow-up; Prognosis; SURVIVAL; QUALITY; CARE; SURVEILLANCE; COMORBIDITY; PHYSICIANS; RESECTION; SURGERY; INDEX; SCORE;
D O I
10.1159/000264623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear whether postoperative follow-up by thoracic surgeons or chest physicians for non-small cell lung cancer (NSCLC) alters survival. Patients and Methods: The charts of 1,398 NSCLC patients, diagnosed between 1980 and 2008, were reviewed. Prognostic factors contained therein were evaluated using univariate and multivariate analyses. Patients were divided into 2 groups according to the doctor in charge of their postoperative follow-up: the thoracic surgeon group and the chest physician group. The doctors in charge of following up the patients were also analyzed for prognostic significance. Results: In the univariate and multivariate analyses, age 65 years or younger, female sex, early pathological stage, Charlson Index score of 0-1, absence of adjuvant therapy, and follow-up by a chest physician were significantly favorable prognostic factors. Examined overall, NSCLC patients in the chest physician group had longer survival than those in the thoracic surgeon group. The difference in survival of patients with advanced disease was also statistically significant between these 2 groups. Conclusions: Our results indicate that early detection of asymptomatic disease by regular follow-up including chest computed tomography scan may improve the chance of treatment with curative intent and thus may increase survival, irrespective of the doctor in charge of follow-up.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [31] Treatment outcomes for Patients with synchronous multiple primary non-small cell lung cancer
    Jung, Eun Jung
    Lee, Jong Hoo
    Jeon, Kyeongman
    Koh, Won-Jung
    Suh, Gee Young
    Chung, Man Pyo
    Kim, Hojoong
    Kwon, O. Jung
    Shim, Young Mog
    Um, Sang-Won
    LUNG CANCER, 2011, 73 (02) : 237 - 242
  • [32] Prognostic Significance of Pre- and Postoperative Glasgow Prognostic Score for Patients with Non-small Cell Lung Cancer
    Tomita, Masaki
    Ayabe, Takanori
    Chosa, Eiichi
    Nakamura, Kunihide
    ANTICANCER RESEARCH, 2014, 34 (06) : 3137 - 3140
  • [33] Prognosis in Patients with Non-Small Cell Lung Cancer and Satellite Tumors
    Kocaturk, C. I.
    Gunluoglu, M. Z.
    Cansever, L.
    Dincer, I. S.
    Bedirhan, M. A.
    THORACIC AND CARDIOVASCULAR SURGEON, 2011, 59 (06) : 360 - 363
  • [34] Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer
    Higashiyama, Masahiko
    Miyazaki, Ryohei
    Yamamoto, Hiroshi
    Anayama, Takashi
    Kikuchi, Shinya
    Hirohashi, Kentaro
    Okami, Jiro
    Maniwa, Tomohiro
    Kimura, Toru
    Orihashi, Kazumasa
    Imamura, Fumio
    BMC CANCER, 2020, 20 (01)
  • [35] Follow-Up Update of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, J-T
    Gao, X.
    Liu, S-Y
    Jiao, Z.
    Dong, S.
    Pan, Y.
    Zhou, Q.
    Zhong, W-Z
    Yang, X-N
    Yi, X.
    Wu, Y-L
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S117 - S117
  • [36] Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
    Ji, Wenhao
    Jiang, Youhua
    Li, Yuetong
    Mao, Weimin
    Teng, Lisong
    NEOPLASMA, 2024, 71 (01) : 88 - 97
  • [37] Feasibility of Extended Postoperative Follow-Up in Patients With Gastric Cancer
    Lee, Ju-Hee
    Kim, Jiyeong
    Choi, Ji Yoon
    JAMA SURGERY, 2024, 159 (09) : 1009 - 1017
  • [38] Value of 18F FDG-PET/CT parameters on long term follow-up for patients with non-small cell lung cancer
    Zoair, Mohammed
    Taber, Samantha
    Bittner, Roland
    Foerster, Gregor
    Griff, Sergej
    Bauer, Torsten T.
    Pfannschmidt, Joachim
    INNOVATIVE SURGICAL SCIENCES, 2022, 7 (02): : 35 - 43
  • [39] Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients
    Lu, Baohua
    Zhang, Hongmei
    Zhang, Tongmei
    Cai, Yiran
    Hu, Ying
    Zheng, Hua
    Li, Baolan
    THORACIC CANCER, 2016, 7 (04) : 486 - 494
  • [40] Risk factors for postoperative pneumonia in patients undergoing resection for non-small cell lung cancer
    Ancin, Burcu
    Uysal, Serkan
    Kumbasar, Ulas
    Dikmen, Erkan
    Dogan, Riza
    PNEUMON, 2023, 36 (03)